Dashenlin Pharm Grp Co Ltd Tangible Net Worth Ratio
Dashenlin Pharm Grp Co Ltd tangible net worth ratio. Dashenlin Pharm Grp Co Ltd (603233) has a Tangible Net Worth Ratio of 78.5% as of March 2026. This metric is calculated by deducting intangible assets (CN¥1.98 Billion) from net assets (CN¥9.18 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check 603233 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Dashenlin Pharm Grp Co Ltd (2012–2025)
Tangible net worth ratio of Dashenlin Pharm Grp Co Ltd from 2012 to 2025. This chart shows how Dashenlin Pharm Grp Co Ltd's Tangible Net Worth Ratio has changed across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 78.5%, reflecting net assets of CN¥9.18 Billion with intangible assets of CN¥1.98 Billion CNY. See Dashenlin Pharm Grp Co Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Dashenlin Pharm Grp Co Ltd Tangible Net Worth Ratio by Year (2012–2025)
Dashenlin Pharm Grp Co Ltd tangible net worth ratio by year from 2012 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Dashenlin Pharm Grp Co Ltd from 2012 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Dashenlin Pharm Grp Co Ltd market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 77.0% | CN¥8.66 Billion | CN¥1.99 Billion | CN¥26.49 Billion | ▲ +1.5 pp |
| 2024 | 75.5% | CN¥8.14 Billion | CN¥1.99 Billion | CN¥26.44 Billion | ▼ -0.8 pp |
| 2023 | 76.3% | CN¥7.93 Billion | CN¥1.88 Billion | CN¥24.12 Billion | ▼ -13.5 pp |
| 2022 | 89.8% | CN¥6.86 Billion | CN¥700.55 Million | CN¥20.84 Billion | ▲ +1.2 pp |
| 2021 | 88.6% | CN¥5.94 Billion | CN¥676.41 Million | CN¥17.34 Billion | ▼ -1.7 pp |
| 2020 | 90.3% | CN¥5.57 Billion | CN¥538.53 Million | CN¥12.33 Billion | ▼ -0.8 pp |
| 2019 | 91.1% | CN¥4.33 Billion | CN¥384.83 Million | CN¥8.67 Billion | ▲ +0.4 pp |
| 2018 | 90.7% | CN¥3.09 Billion | CN¥287.63 Million | CN¥6.54 Billion | ▼ -5.2 pp |
| 2017 | 95.9% | CN¥2.80 Billion | CN¥114.12 Million | CN¥5.82 Billion | ▲ +0.9 pp |
| 2016 | 95.0% | CN¥1.34 Billion | CN¥67.10 Million | CN¥3.58 Billion | ▲ +1.3 pp |
| 2015 | 93.7% | CN¥1.02 Billion | CN¥63.85 Million | CN¥2.66 Billion | ▲ +2.4 pp |
| 2014 | 91.3% | CN¥574.85 Million | CN¥49.99 Million | CN¥2.37 Billion | ▼ -1.7 pp |
| 2013 | 93.0% | CN¥589.93 Million | CN¥41.08 Million | CN¥1.68 Billion | ▲ +2.2 pp |
| 2012 | 90.8% | CN¥381.11 Million | CN¥34.93 Million | CN¥996.51 Million | — |